Inhibrx Biosciences, Inc.盘中异动早盘股价大涨5.45%

市场透视2025-09-26

北京时间2025年09月26日22时09分，Inhibrx Biosciences, Inc.（INBX.us）股票出现波动，股价快速上涨5.45%。截至发稿，该股报33.58美元/股，成交量1.7826万股，换手率0.12%，振幅5.40%。最近的财报数据显示，该股实现营业收入1.30百万美元，净利润-28.65百万美元，每股收益-1.85美元，毛利638000.00美元，市盈率-1.98倍。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2570085907?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-09-26 22:09","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2570085907","market":"us","top_or_hot":-1,"title":"Inhibrx Biosciences, Inc.盘中异动 早盘股价大涨5.45%","media":"市场透视","content":"<div>\n<p>北京时间2025年09月26日22时09分，Inhibrx Biosciences, Inc.（INBX.us）股票出现波动，股价快速上涨5.45%。截至发稿，该股报33.58美元/股，成交量1.7826万股，换手率0.12%，振幅5.40%。最近的财报数据显示，该股实现营业收入1.30百万美元，净利润-28.65百万美元，每股收益-1.85美元，毛利638000.00美元，市盈率-1.98倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250926220912954716ea&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inhibrx Biosciences, Inc.盘中异动 早盘股价大涨5.45%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInhibrx Biosciences, Inc.盘中异动 早盘股价大涨5.45%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-09-26 22:09 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250926220912954716ea&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年09月26日22时09分，Inhibrx Biosciences, Inc.（INBX.us）股票出现波动，股价快速上涨5.45%。截至发稿，该股报33.58美元/股，成交量1.7826万股，换手率0.12%，振幅5.40%。最近的财报数据显示，该股实现营业收入1.30百万美元，净利润-28.65百万美元，每股收益-1.85美元，毛利638000.00美元，市盈率-1.98倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250926220912954716ea&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"INBX","symbol_name":"Inhibrx Biosciences","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250926220912954716ea&s=b","article_id":"2570085907","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250926220912954716ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2570085907","pubTimestamp":1758895752,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年09月26日22时09分，Inhibrx Biosciences, Inc.股票出现波动，股价快速上涨5.45%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Plus Therapeutics, Inc.、Applied Therapeutics, Inc.、Crinetics Pharmaceuticals, Inc.涨幅较大，Soligenix, Inc.、Onconetix, Inc.、Fractyl Health, Inc.较为活跃，换手率分别为91.09%、76.85%、67.78%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 、Applied Therapeutics, Inc.、Curanex Pharmaceuticals Inc，振幅分别为29.41%、26.03%、25.04%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"INBX":"Inhibrx Biosciences","BK4139":"生物科技"},"translate_title":"Inhibrx Biosciences, Inc. Shares jumped 5.45% in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INBX":1.5},"content_text":"北京时间2025年09月26日22时09分，Inhibrx Biosciences, Inc.（INBX.us）股票出现波动，股价快速上涨5.45%。截至发稿，该股报33.58美元/股，成交量1.7826万股，换手率0.12%，振幅5.40%。最近的财报数据显示，该股实现营业收入1.30百万美元，净利润-28.65百万美元，每股收益-1.85美元，毛利638000.00美元，市盈率-1.98倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Plus Therapeutics, Inc.、Applied Therapeutics, Inc.、Crinetics Pharmaceuticals, Inc.涨幅较大，Soligenix, Inc.、Onconetix, Inc.、Fractyl Health, Inc.较为活跃，换手率分别为91.09%、76.85%、67.78%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts (To Pur Com)、Applied Therapeutics, Inc.、Curanex Pharmaceuticals Inc，振幅分别为29.41%、26.03%、25.04%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。其临床治疗候选药物包括INBRX-109和INBRX-106，这两种药物均采用多价形式，可以以靶向为中心的方式优化精确的价态，以调节专家认为是主要的激动剂功能。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2570085907","isCrawlerRequest":true}

Inhibrx Biosciences, Inc.盘中异动 早盘股价大涨5.45%

精彩评论

Inhibrx Biosciences, Inc.盘中异动早盘股价大涨5.45%